3 Things You Should Know About Recognizing LEMS in Patients With SCLC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 92
- Publication type:
- Article
Works matching IS 08909091 AND DT 2025 AND VI 39 AND IP 2
Results: 9
1
2
3 Things You Should Know About Treating Epithelioid Sarcoma.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 88
- Publication type:
- Article
3
Sotorasib Combo Bests Chemo Leading to Approval in KRAS G12C+ CRC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 85
- By:
- Publication type:
- Article
4
Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 80, doi. 10.46883/2025.25921036
- By:
- Publication type:
- Article
5
3 Things You Should Know About Managing ALK+ Metastatic NSCLC.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 76
- Publication type:
- Article
6
Updates in Surgical Management of the Axilla.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 70, doi. 10.46883/2025.25921035
- By:
- Publication type:
- Article
7
Five-Year Impact of the COVID-19 Pandemic on the Oncology Community.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 66
- Publication type:
- Article
8
Integrating Psilocybin-Assisted Psychotherapy Into Comprehensive Cancer Care.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 63
- By:
- Publication type:
- Article
9
Five Years After the COVID-19 Pandemic: Effects on Cancer Care.
- Published in:
- Oncology (08909091), 2025, v. 39, n. 2, p. 57
- By:
- Publication type:
- Article